Status:
COMPLETED
Inter-fascial Plane Between the SArtorius Muscle and FEmoral Artery (ISAFE)
Lead Sponsor:
University of Toronto
Collaborating Sponsors:
Mount Sinai Hospital, Canada
Conditions:
Anesthesia, Conduction
Arthroplasty, Replacement, Knee
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Total knee arthroplasty (TKA) is a frequent performed surgery. Adequate pain management is an important feature. Analgesic duration of single shot nerve blocks is limited to no more than 24h. Converse...
Detailed Description
Introduction Total knee arthroplasty (TKA) is an effective treatment for end stage osteoarthritis, with over 75,000 TKA performed in Canada annually (https://www.cihi.ca/en/hip-and-knee-replacements-i...
Eligibility Criteria
Inclusion
- Patients undergoing primary or revision Total Knee Arthroplasty in the inpatient setting. Non-pregnant patients older than 21 years of age, with American Society of Anesthesiologists (ASA) physical status I-IV.
Exclusion
- Patients undergoing outpatient TKA. Chronic opioid use of oral morphine 30mg equivalent per day for last 2 consecutive weeks. Patients with contraindications to the insertion of an adductor canal catheter (severe anatomic abnormalities, local or systemic infection, or a history of previous surgery at the site of catheter placement).
Key Trial Info
Start Date :
April 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 28 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05313269
Start Date
April 28 2022
End Date
March 28 2023
Last Update
June 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
Toronto, Ontario, Canada, M5G 1X5